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Ca2+/calmodulin-dependent protein kinase phosphatase (CaMKP/PPM1F) and its nuclear homolog CaMKP-N (PPM1E) are
Ser/Thr protein phosphatases that belong to the PPM family. CaMKP-N is expressed in the brain and undergoes proteolytic
processing to yield a C-terminally truncated form. The physiological significance of this processing, however, is not fully
understood. Using a wheat-embryo cell-free protein expression system, we prepared human CaMKP-N (hCaMKP-N(WT))
and the truncated form, hCaMKP-N(1–559), to compare their enzymatic properties using a phosphopeptide substrate. The
hCaMKP-N(1–559) exhibited a much higher 𝑉max value than the hCaMKP-N(WT) did, suggesting that the processing may be a
regulatory mechanism to generate a more active species. The active form, hCaMKP-N(1–559), showed Mn2+ or Mg2+-dependent
phosphatase activity with a strong preference for phospho-Thr residues and was severely inhibited by NaF, but not by okadaic acid,
calyculin A, or 1-amino-8-naphthol-2,4-disulfonic acid, a specific inhibitor of CaMKP. It could bind to postsynaptic density and
dephosphorylate the autophosphorylated Ca2+/calmodulin-dependent protein kinase II. Furthermore, it was inactivated by H
2
O
2
treatment, and the inactivation was completely reversed by treatment with DTT, implying that this process is reversibly regulated
by oxidation/reduction. The truncated CaMKP-N may play an important physiological role in neuronal cells.
1. Introduction
Ca2+/calmodulin-dependent protein kinase phosphatase
(CaMKP/PPM1F/POPX2) was first identified in rat brain as
a unique protein phosphatase that specifically dephosphoryl-
ates and regulatesmultifunctional CaMKs, includingCaMKI,
II, and IV [1–4].Thereafter, another protein phosphatase with
52% identity in the catalytic domain to human CaMKP was
found in the human cDNA databases (Figure 1(a)). When
the cDNA was expressed in COS cells, the phosphatase
encoded by the cDNA was localized to the nucleus, in
contrast to CaMKP, which was exclusively found in the
cytosol. Therefore, we named the enzyme CaMKP-N for
its localization in the nucleus [5]. Subsequently, other
groups named this enzyme POPX1 [6] or PPM1E [7] and
reported that it is involved in the negative regulation of the
p21-activated protein kinase [6] and the 5󸀠-AMP-activated
protein kinase [7]. Gene knockdown experiments for
zebrafish CaMKP-N (zCaMKP-N) using morpholino-based
antisense oligonucleotides indicated that CaMKP-N is
essential for the early development of the brain and spinal
cord in zebrafish [8].
We also showed that the proteolytic processing of
zCaMKP-N plays a critical role in the regulation of its
catalytic activity, subcellular localization, and substrate tar-
geting [9]. In accordance with these results, Kitani et al.
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Figure 1: Schematic representation of hCaMKP, hCaMKP-N(WT), hCaMKP-N(1–559), and zCaMKP-N. (a) Comparison of the primary
structure of hCaMKP-N with that of hCaMKP. The regions that show significant homology are shown in grey. (b) Domain structures
of hCaMKP-N(WT), hCaMKP-N(1–559), and z-CaMKP-N. Catalytic domains are shown in dark grey, and the hatched bars within them
indicate the PP2Cmotif that is characteristic of PPM family phosphatases. Black bars show the antibody recognition site. In hCaMKP-N, the
recognition site is located just to the N-terminal side of the putative processing site.The amino acid sequences of the antibody recognition site
in human, rat, and zebrafish CaMKP-N are also indicated. Underline shows the amino acid sequence used for generating the anti-CaMKP-N
antibody. Closed arrowheads show the position of Cys436, which may be responsible for redox regulation of the phosphatase activity (see
text). It has been reported that two nuclear localization signals are located in the region that is C-terminal side to Arg668 on hCaMKP-N
(shown in light grey). The 575–587 region of zCaMKP-N reportedly functions as a nuclear localization signal (shown in light grey) [8]. The
amino acid residue numbers of the respective phosphatases are also shown.
[10] suggested that the majority of CaMKP-N undergoes
proteolytic processing to generate a 90 kDa fragment in
rat brain that is localized to the cytosol. Since the amino
acid sequence homology between zCaMKP-N and human
CaMKP-N (hCaMKP-N) is only 48% and the molecular size
of zCaMKP-N is much smaller than the size of hCaMKP-N
(by more than 100 amino acid residues, Figure 1(b)), it is dif-
ficult to predict, on the basis of sequence homology, whether
the 90 kDa fragment is a mammalian counterpart for the
active fragment of zCaMKP-N that is generated by proteolytic
processing in zebrafish. It is clinically significant to explore
the enzymatic properties of hCaMKP-N, which may provide
a molecular basis for drug development because CaMKP-
N has been suggested to regulate the 5󸀠-AMP-activated
protein kinase involved in the pathogenesis of diabetes
[7]. Unfortunately, difficulty in preparing hCaMKP-N in a
sufficient purity and quantity has hampered the biochemical
characterization of this enzyme. Our initial attempt to obtain
pure full-length hCaMKP-N using transfected Sf9 cells failed
due to proteolysis during the expression and purification.We
performed only a preliminary characterization of hCaMKP-
N using a mixed preparation that contained both full-length
hCaMKP-N and its truncated fragment, which was gener-
ated during the preparation [5]. Therefore, no information
has been available about the enzymatic properties and the
physiological importance of each species of hCaMKP-N.
In this study, we utilized a wheat-embryo cell-free protein
expression system to separately prepare full-length hCaMKP-
N and hCaMKP-N(1–559), a human counterpart to the
90 kDa truncated fragment found in the rat brain. Using these
preparations, we compared the kinetic properties of full-
length hCaMKP-Nand the truncated fragment, andwe found
that the truncated fragment had much higher phosphatase
activity than the full-length form. We also examined the
enzymatic properties of the truncated hCaMKP-N, which
had not been characterized in detail, and discussed the
physiological importance of the processing.
2. Materials and Methods
2.1. Materials. The phosphopeptides, pp2 (MHRQET(p)
VDC), pp4 (MHRQES(p)VDC), pp6 (MHRQEY(p)VDC),
and pp10 (YGGMHRQET(p)VDC), were synthesized using
a Shimadzu PSSM-8 automated peptide synthesizer and
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purified by reverse-phase HPLC on a C
18
column [5, 11].
The identity and purity of the peptides were confirmed by
time-of-flight mass spectrometry. The postsynaptic density
(PSD) fraction was purified from rat cerebral cortex as
described by Sahyoun et al. [12].The anti-CaMKP-Nantibody
was obtained as previously described [8]. Monoclonal anti-
CaMKII𝛼 (MAb CB𝛼-2) was purchased from Life Tech-
nologies. The anti-active CaMKII was from Promega. The
biotin-conjugated rabbit anti-mouse IgG was obtained from
ZYMED. The anti-rabbit Ig, biotinylated species-specific
antibody, streptavidin-conjugated horseradish peroxidase,
and the Ni2+-Sepharose high-performance resin were from
GE Healthcare. An enhanced chemiluminescence detection
agent, SuperSignal West Femto Maximum Sensitivity Sub-
strate, was from Thermo Scientific. DNase-free RNase was
from Boeringer Mannheim. Hydrogen peroxide, Quick CBB,
and okadaic acid were purchased fromWako Pure Chemical
Industries, and the 1-amino-8-naphthol-2,4-disulfonic acid
(ANDS)was fromTokyoChemical Industry. Calyculin Awas
fromMillipore/Upstate. All other agents were obtained from
Nacalai Tesque or Sigma-Aldrich.
2.2. Construction of Plasmids. The pEU-E01-CaMKPN vec-
tor, which encodes the wild type (WT) hCaMKP-N with
an N-terminal 6x His tag, was prepared as described in
the following. The following primers were used for PCR:
CaMKPNHis-UP1 (5󸀠-GGA TAT CTATGTCGTACTACC
ATC ACC ATC ACC ATC ACG CCG GCT GCA TCC
CTG AGG AGA A-3󸀠) with an EcoRV site (underlined)
and CaMKPN LP1 (5󸀠-GGT CGA CTT ATT CTA TTT TAT
AGC TCC AAG GAA GAT-3󸀠) with a SalI site (underlined).
The PCR was performed in a PTC-200 Thermal Cycler (MJ
Research) for 20 cycles, each consisting of denaturation for
5 s at 98∘C, annealing for 30 s at 60∘C, and extension for
2min at 68∘C, in the presence of 3% (v/v) dimethyl sulfoxide
using Pyrobest DNA Polymerase (Takara) and the plasmid
DNA containing hCaMKP-N cDNA (AK289966, HuPEX
clone FLJ76651) as the template. After gel purification, the
amplified product was digested with EcoRV and SalI and
cloned into pCR4Blunt-TOPO (Invitrogen). The plasmid
DNA was then sequenced with the ABI PRISM 3100 Genetic
Analyzer (Applied Biosystems) to confirm theDNA sequence
of the cloned insert. The plasmid was digested with EcoRV
and SalI, and the insert purified by gel purificationwas ligated
into pEU-E01-MCS (CellFree Science) at the EcoRV and SalI
sites to generate pEU-E01-CaMKPN, which encodes the full-
length hCaMKP-Nwith an N-terminal 6×His-tag.The pEU-
E01-CaMKPN(1–559) vector, which encodes the C-terminal
deletion mutant hCaMKP-N(1–559) with an N-terminal 6×
His tag, was prepared using an inverse PCR mutagenesis
kit (KOD-Plus-Mutagenesis Kit, TOYOBO) according to the
manufacturer’s instructions, with pEU-E01-CaMKPN as the
template. The PCR was performed in a PC707 Thermal
Cycler (ASTEC) for 10 cycles, each consisting of denaturation
for 10 s at 98∘C, annealing for 30 s at 60∘C, and extension
for 6min at 68∘C, in the presence of 4.8% (v/v) dimethyl
sulfoxide with the sense primer (5󸀠-TAG ATC CCA AAT
CAA CGT GCT GGA AGA C-3󸀠, underline shows the site of
mutation) and the antisense primer (5󸀠-TGGGCTCAGGCT
AGT TCT ATC AGT G-3󸀠). The PCR product was digested
with DpnI, and after gel purification, the amplified product
was phosphorylated and self-ligated to generate pEU-E01-
CaMKPN(1–559). The sequence of the mutated insert was
confirmed by DNA sequencing.
2.3.TheCell-Free Expression of Recombinant hCaMKP-Ns and
Its Purification. Cell-free expression of hCaMKP-N(WT)
and hCaMKP-N(1–559) was carried out using a wheat-
embryo cell-free protein expression system, the WEPRO
1240H Expression Kit (CellFree Sciences), according to the
manufacturer’s instruction, with either pEU-E01-CaMKPN
or pEU-E01-CaMKPN(1–559). The in vitro translation reac-
tions were conducted in a 96-well microtiter plate at 15∘C for
18–20 hs. After the translation reaction, DNase-free RNase
(24𝜇g/mL) and the cOmplete Mini EDTA-free protease
inhibitor cocktail (Roche) (1 tablet/10mL) were added to the
translation reaction mixture, and the mixture was incubated
for 30min on ice. To 3mL of the mixture, 0.96mL of 50%
(v/v) suspension of Ni2+-Sepharose resin, which had been
equilibrated and suspended in 20mM Tris-HCl (pH 7.5)
containing 0.2% (v/v) Tween 40, 10mM imidazole, 300mM
NaCl, and 1mM DTT, was added, and the mixture was then
gently rocked at 4∘C for 1 h. All of the following purification
procedures were carried out at 4∘C. The gel slurry was
poured into an empty column (0.12 × 14 cm), and the flow-
through fraction was allowed to drain. The column was
washed with 5mL of 20mM Tris-HCl (pH 7.5) containing
0.05% (v/v) Tween 40, 20mM imidazole, 1.5M NaCl, and
1mM DTT. For CaMKP-N(WT), the column was further
washed with 2.5mL of 20mM Tris-HCl (pH 7.5) containing
0.05% (v/v) Tween 40, 100mM imidazole, 300mM NaCl,
and 1mM DTT, or for CaMKP-N(1–559), the column was
further washed with 20mM Tris-HCl (pH 7.5) containing
0.05% (v/v) Tween 40, 40mM imidazole, 300mMNaCl, and
1mM DTT. The column was eluted with 2.5mL of 20mM
Tris-HCl (pH 7.5) containing 0.05% (v/v) Tween 40, 250mM
imidazole, 300mMNaCl, and 1mMDTT, and the eluate was
concentrated using a centrifugal filter unit (10,000 MWCO,
Millipore). Glycerol was added to a final concentration of
30% (v/v). The purified enzymes were aliquoted and could
be stored at −80∘C for several months without any detectable
loss in activity.
2.4. Protein Phosphatase Assays. Protein phosphatase assays
using a phosphopeptide as a substrate were performed as
previously described [13]. The phosphopeptides used in
this study were derived from the amino acid sequence
around the Thr286 autophosphorylation site on CaMKII𝛼
(CaMKII(281–289) = pp2) or its analogs (pp4, pp6, pp10).The
reaction was initiated by adding enzyme, and the reaction
mixture was incubated at 30∘C for 45min. The amount
of inorganic phosphate released in the mixture during the
incubation was determined by malachite green assay [11].
The Michaelis-Menten kinetic parameters were determined
from a direct fit to the Michaelis-Menten equation using
a nonlinear regression program (DeltaGraph, version 6.0,
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Red Rock Software) as previously described [11]. The tested
compounds were added to the reaction systems mentioned
above at the indicated concentrations.
The protein phosphatase assay using autophosphorylated
CaMKII as a phosphoprotein substrate was performed as
described [13] with the following modifications. The PSD
fraction (905𝜇g/mL) was incubated at 5∘C for 10min in
the reaction mixture (100𝜇L) containing 40mM Hepes-
NaOH (pH 8.0), 5mMMg(CH
3
COO)
2
, 0.1mM EGTA, 1 𝜇M
calmodulin, 0.8mM CaCl
2
, 0.01% Tween 20, and 50 𝜇M
nonradioactiveATP to autophosphorylate theCaMKII found
in the PSD fraction. After the reaction, the mixture was
immediately diluted with 1mL of ice-cold wash buffer con-
sisting of 50mM Tris-HCl (pH 7.5), 0.2M NaCl, 0.05%
Tween 40, 0.1 𝜇M calyculin A, and 0.1mM DTT, and then
it was centrifuged for 10min at 4∘C in a microcentrifuge
at maximum speed. The supernatant was removed, and the
precipitate was resuspended with the ice-cold wash buffer
and centrifuged again as described previously. The washing
procedure was repeated five more times. The precipitate
obtainedwas resuspended in 100𝜇L of thewashing buffer and
stored at −80∘C until it was used. The phosphatase reaction
was carried out in a reactionmixture containing 50mMTris-
HCl (pH 7.5), 2mMMnCl
2
, 0.1mM EGTA, and 0.01% Tween
20.Western blotting analysis using anti-active CaMKII (anti-
PCaMKII, 1 : 1000 dilution) was performed to estimate the
extent of autophosphorylation at theThr286 site on CaMKII.
After the detection of autophosphorylated CaMKII, the blot
was treated with Blot Restorte Membrane Rejuvenation Kit
(Millipore) according to the manufacturer’s instructions, so
that it could be reprobed. To confirm the amount of total
CaMKII on the blot, the rejuvenated blot was reprobed with
a monoclonal anti-CaMKII𝛼 (CB𝛼-2, 1 : 500 dilution).
2.5. Binding of hCaMKP-N(1–559) to PSD. hCaMKP-N(1–
559) (1 𝜇g) was incubated with the PSD fraction (1𝜇g) in
50mM Tris-HCl (pH 7.5) (10𝜇L) on ice for 1 h and then
centrifuged for 5min at 4∘C in a microcentrifuge at maxi-
mum speed. The pellet fraction was suspended with ice-cold
50mMTris-HCl (pH 8.1) containing 0.85% NaCl (1mL), and
the suspension was centrifuged as described previously. The
washing procedure was repeated, and the pellet fraction was
resuspended in a minimum volume of 50mM Tris-HCl (pH
8.1) containing 0.85% NaCl. An equal volume of 2× SDS-
sample buffer was added to the suspension to prepare the
samples for western blotting analysis.
2.6. Western Blotting Analysis. The protein samples were
separated by gel electrophoresis and transferred onto an
Immobilon-P polyvinylidene difluoride membrane (Milli-
pore) as previously described [14]. After blocking, the mem-
brane was incubated overnight at 4∘C with primary anti-
bodies and then incubated with the biotinylated rabbit anti-
mouse IgG (1 : 2000 dilution) or anti-rabbit Ig biotinylated
species-specific antibody (1 : 2000 dilution) for 2 h at room
temperature. This step was followed by incubation with a
streptavidin-horseradish peroxidase conjugate (1 : 500 dilu-
tion) for 40min at room temperature.The western blots were
visualized by an enhanced chemiluminescence detection
procedure using LAS-1000 (GE Healthcare) image analyzers.
2.7. Other Analytical Methods. SDS-PAGE was carried out
according to the Laemmli method [15]. Protein concen-
trations were determined using an advanced protein assay
reagent (cytoskeleton) with bovine serum albumin as a
standard. The concentrations of the pp2 and pp4 peptides
were determined by measuring the Pi released after alkali
hydrolysis as previously described [11]. The concentration
of the pp6 peptide was determined by measuring the Pi
released after acid hydrolysis as previously described [11].
The concentration of the pp10 peptide was determined
spectrophotometrically using the absorption coefficient for
tyrosine (𝜀
278
= 1.16 × 10
3M−1 cm−1).
3. Results
3.1. Preparation of hCaMKP-N and hCaMKP-N(1–559) Using
a Wheat-Embryo Cell-Free Protein Expression System. It
has been reported that CaMKP-N undergoes proteolytic
processing in the rat brain to generate a 90 kDa fragment
in which the C-terminal region is truncated [10]. In an
attempt to evaluate the physiological significance of the
C-terminal truncation of hCaMKP-N, we prepared full-
length and truncated hCaMKP-N to compare their enzymatic
properties. Kitani et al. [10] reported that rat CaMKP-N is
truncated at or near Pro554. Since the amino acid sequence
identity between rat and human CaMKP-N is very high
(88%) [16], we constructed expression plasmids for the full-
length hCaMKP-N (hCaMKP-N(WT)) and for the truncated
hCaMKP-N fragment, in which the C-terminal side of the
corresponding Pro residue (Pro559) was deleted, (hCaMKP-
N(1–559)), and both contain an added 6× His-tag at their
N-terminus (Figure 1(b)). Using the expression plasmids
as templates, we synthesized the full-length hCaMKP-N
and hCaMKP-N(1–559) proteins with a wheat-embryo cell-
free protein expression system and purified these enzymes
by Ni2+-Sepharose affinity chromatography as described in
Section 2. The purified hCaMKP-N(WT) and hCaMKP-
N(1–559) showed apparent molecular masses of approx-
imately 120 kDa and 90 kDa on SDS-PAGE, respectively
(Figure 2(a)), which are in good agreement with the previous
report [5]. Both enzymes were detected by the anti-CaMKP-
N antibody that was raised against a synthetic peptide corre-
sponding to the 474–488 region of zCaMKP-N (Figure 2(b)).
Because this region shares fairly high homology with the
region that is N-terminal side to Pro559 on hCaMKP-N
(Figure 1(b)) [8], it was confirmed that the purified phos-
phatases retained the N-terminal side of Pro559. It should be
noted that the hCaMKP-N(WT) preparation was essentially
free from the 90 kDa proteolytic fragment usually seen in the
preparations purified from the baculovirus-transfected Sf9
cells [5].
3.2. Activation of hCaMKP-N by C-Terminal Truncation.
Using the protein preparations described previously, the
BioMed Research International 5
1 2
(k
D
a)
160
110
80
60
50
WT 1–559
(a)
120
80
60
1 2
(k
D
a)
WT 1–559
(b)
Figure 2: hCaMKP-N and its truncation mutant prepared by a
wheat-embryo cell-free protein expression system. (a) hCaMKP-
N(WT) (lane 1, 2.5𝜇g) and hCaMKP-N(1–559) (lane 2, 2.5 𝜇g),
which had been prepared and purified as described in Section 2,
were subjected to SDS-PAGE on a 10% polyacrylamide gel. The gel
was stained with Coomassie Brilliant Blue (CBB) using Quick CBB.
(b) hCaMKP-N(WT) (lane 1) and hCaMKP-N(1–559) (lane 2) were
subjected to SDS-PAGE on a 10% polyacrylamide gel and analyzed
by western blotting analysis using an anti-CaMKP-N antibody
(1 : 250 dilution) as the primary antibody.
kinetic properties of hCaMKP-N(WT) and hCaMKP-N(1–
559) were evaluated and compared. The phosphatase activ-
ities were assessed under the standard assay conditions for
CaMKP and CaMKP-N [5, 11], where they were assayed in
the presence of 2mM Mn2+ using the pp10 phosphopep-
tide as a substrate (Figure 3). hCaMKP-N(1–559) showed
much higher activity than hCaMKP-N(WT). We performed
a kinetic analysis of hCaMKP-N(WT) and hCaMKP-N(1–
559) with varying concentrations of the pp10 substrate.
They displayed typical Michaelis-Menten kinetics, and the
𝐾
𝑚
value for pp10 and the 𝑉max value were determined
(Figure 3, Table 1). These parameters strongly suggested that
the truncation of theC-terminal region of hCaMKP-N results
in a marked increase in the 𝑉max for the phosphatase activity.
3.3. Some Enzymatic Properties of hCaMKP-N(1–559). Since
the C-terminally truncated form has been reported to be
the most abundant species of CaMKP-N in the rat brain
[10], the enzymatic properties of hCaMKP-N(1–559) were
further examined using pp10 as the substrate. As shown in
Figure 4(a), the truncated fragment showed a strong Mn2+-
dependent phosphatase activity and a weakMg2+-dependent
phosphatase activity but no Ca2+-dependent activity. We also
examined the effect of varying concentrations of Mn2+and
Mg2+ on the phosphatase activity (Figure 4(b)). Only a
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Figure 3: Dephosphorylation of a phosphopeptide substrate pp10
by hCaMKP-N(WT) and hCaMKP-N(1–559). The indicated con-
centrations of pp10 were dephosphorylated by hCaMKP-N(WT)
(open circles) and by hCaMKP-N(1–559) (closed circles) at 30∘C
as described in Section 2. The amount of inorganic phosphate
released in the reactionmixture during the reaction was determined
as described. The indicated curves were obtained by direct fits
of the data to Michaelis-Menten equation. The data shown are
those in a representative experiment of at least three independent
determinations with similar results.
Table 1: Comparison of the phosphatase activities of hCaMKP-
N(WT) and hCaMKP-N(1–559). hCaMKP-N(WT) and hCaMKP-
N(1–559)were assayed using varying concentrations of the pp10 sub-
strate as described in Section 2. Michaelis-Menten kinetic param-
eters were determined from a direct fit to the Michaelis-Menten
equation. The data represent the average of three independent
experiments ± S.D.
𝐾
𝑚
(𝜇M) 𝑉max (nmol/min/mg)
hCaMKP-N(WT) 2.0 ± 0.9 1.4 ± 0.1
hCaMKP-N(1–559) 5.4 ± 0.1 16.3 ± 3.6
submillimolar concentration of Mn2+ was required for the
full activity of hCaMKP-N(1–559), whereasmore than 10mM
Mg2+ was required for the same level of activity. A kinetic
analysis revealed that the half-maximal activations for Mn2+
andMg2+ are 0. 22±0.04mM and 6.4±1.6mM, respectively.
It should be noted that almost the same level of full activity
was observed at their saturating levels, regardless of whether
Mn2+ or Mg2+ was used as a cofactor.
It has been reported that PPM family phosphatases,
including PP2C and CaMKP, strongly prefer phospho-Thr
over phospho-Ser as the residue to be dephosphorylated
[11, 17]. Therefore, we examined the phosphoamino acid
residue preference of hCaMKP-N(1–559). For this purpose,
6 BioMed Research International
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Figure 4:The divalent cation requirement for the phosphatase activity of hCaMKP-N(1–559). (a) hCaMKP-N(1–559) was assayed using pp10
as the substrate in the presence of the indicated divalent cations or EDTA instead of 2mM MnCl
2
as described in Section 2. The results are
expressed as the percentage of the activity determined with 2mMMnCl
2
. The data represent the average of three independent experiments
± S.D. (b) hCaMKP-N(1–559) was assayed using pp10 as the substrate in the presence of varying concentrations of MnCl
2
(circles) or MgCl
2
(triangles) instead of 2mMMnCl
2
.
a synthetic phospho-CaMKII(281–289) peptide (named pp2)
and its analogs, in which phospho-Thr was replaced with
phospho-Ser (named pp4) or with phospho-Tyr (named
pp6), were used as substrates for hCaMKP-N(1–559). The
truncated hCaMKP-N efficiently dephosphorylated the par-
ent phospho-Thr peptide pp2, but it barely dephosphory-
lated the phospho-Ser peptide (pp4) and the phospho-Tyr
peptide (pp6), indicating strong preference for phospho-Thr
residues as was observed for other PPM family phosphatases
(Figure 5).
The effects of some protein phosphatase inhibitors on
hCaMKP-N(1–559) were also examined and are shown in
Figure 6. Okadaic acid (1𝜇M) and calyculin A (1𝜇M), potent
PP1 and PP2A inhibitors, had no effect on the phosphatase
activity.This is because hCaMKP-N is classified as PPM fam-
ily phosphatases of which structures are quite different from
those of PPP family phosphatases such as PP1 and PP2A. In
contrast, NaF (100mM) and EDTA (10mM) severely inhib-
ited the phosphatase. It is interesting that ANDS, a CaMKP-
specific inhibitor [18], did not inhibit the phosphatase activity
of hCaMKP-N(1–559) even at 30𝜇M, a concentration at
which the rat CaMKP was strongly inhibited.
3.4. Dephosphorylation of the Autophosphorylated CaMKII
in PSD by hCaMKP-N(1–559). CaMKII, one of the can-
didates for the physiological substrate of hCaMKP-N(1–
559), is known to exist abundantly in PSD. Therefore, we
examined interaction of hCaMKP-N(1–559) and the rat brain
PSD as described in Section 2. The endogenous rat CaMKP-
N fragment was not detected in the isolated PSD fraction
prepared from the rat brain (Figure 7(a), lane 1). Sequence
pp2(PT) pp4(PS) pp6(PY)
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Figure 5: The residue preference at the dephosphorylation site.
hCaMKP-N(1–559) was assayed using the indicated phosphopep-
tides (20𝜇M) as substrates under the standard assay conditions as
described in Section 2. The results are expressed as a percentage
of the activity determined using pp2 as the substrate. The data
represent the average of three independent experiments ± S.D.
homology between the rat and human CaMKP-N and the
sequence homology between the rat and human CaMKII𝛼
are very high (88% and 99% identity, resp.). After the PSD
fractionwas incubated with hCaMKP-N(1–559) on ice for 1 h,
a significant amount of the CaMKP-N fragment was detected
in the PSD fraction (Figure 7(a), lane 2).
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Figure 6:The effects of various inhibitors on the phosphatase activ-
ity of hCaMKP-N(1–559). hCaMKP-N(1–559) was assayed using
pp10 as the substrate in the presence of the indicated compounds.
The results are expressed as a percentage of the activity determined
with no compound added (control). The abbreviations used in
the figure are as follows: OA: okadaic acid; CA: calyculin A;
ANDS: 1-amino-8-naphthol-2,4-disulfonic acid. The data represent
the average of three independent experiments ± S.D.
Since the PSD-associated CaMKP-N fragment may play
a physiological role, the phosphatase activity of hCaMKP-
N(1–559) on the autophosphorylated CaMKII was exam-
ined. The endogenous CaMKII in the rat PSD fraction was
autophosphorylated in the presence of Ca2+/calmodulin and
was used as a substrate for hCaMKP-N(1–559). Under the
autophosphorylation conditions used, no significant band
shift for the CaMKII𝛼 subunit was observed by SDS-PAGE.
As shown in Figure 7(b), the autophosphorylated CaMKII
was dephosphorylated by hCaMKP-N(1–559) (lane 2).There-
fore, hCaMKP-N(1–559) can bind to PSD to dephosphorylate
the autophosphorylated CaMKII.
3.5.TheReversible Regulation of hCaMKP-N(1–559) byOxida-
tion/Reduction. We have reported that incubation of human
CaMKPwithH
2
O
2
leads to the formation of a disulfide bond,
which results in inactivation of the enzyme [19]. As shown
in Figure 8(a), H
2
O
2
also inactivated hCaMKP-N(1–559) in
a dose-dependent manner. When the inactivated hCaMKP-
N(1–559) was further incubated on ice for 30min with the
reducing agent DTT, the phosphatase activity was restored
to almost original levels (Figure 8(b)). This indicates that the
inactivation of hCaMKP-N(1–559) by H
2
O
2
is a reversible
process and that hCaMKP-N(1–559) is reversibly regulated by
oxidation/reduction.
4. Discussion
Based on the subcellular localization of transiently expressed
hCaMKP-N in COS cells [5], it had been assumed that mam-
malian CaMKP-N is localized only in the nucleus. However,
Kitani et al. [10] showed that in the rat brain, CaMKP-N
undergoes proteolytic processing to form a 90 kDa fragment
that is localized mainly in the cytosol. Similar proteolytic
fragment of CaMKP-N was also found in human frontal
cortex [20].Therefore, the truncated formof hCaMKP-Nmay
have important functions in cells.
In this study, we used a wheat-embryo cell-free protein
expression system for preparation of hCaMKP-N and its
fragment to minimize proteolysis during the expression and
purification of hCaMKP-N. Using this system in conjunction
with conventional Ni2+-NTA agarose chromatography, we
were able to individually prepare the full-length hCaMKP-
N, hCaMKP-N(WT), and its proteolytic fragment, hCaMKP-
N(1–559), for the first time without mutual contamination.
Typically, approximately 15 𝜇g of purified hCaMKP-N or its
fragment could be obtained from 1 well of a translation
reaction mixture (21 𝜇L of the wheat-embryo translation
mixture and 206 𝜇L of the substrate solution) in a 96-well
microtiter plate (data not shown). The wheat-embryo cell-
free protein expression system has been proven useful for
the preparation of the proteins that are readily degraded by
cellular proteases. Because the protease activities detected in
the cell-free system are very low [21, 22], this method may
be applicable to other protease-sensitive proteins that are
difficult to prepare using conventional cell-based expression
systems such as Sf9 cells.
Using these preparations, we could rigorously compare
the catalytic properties of hCaMKP-N(1–559) and hCaMKP-
N(WT). Both hCaMKP-N species have phosphatase activities
in the presence of Mn2+ toward the pp10 phosphopeptide
substrate, which was based on the amino acid sequence
around the critical Thr286 autophosphorylation site on
CaMKII. This result indicates that the proteolytic fragment
is not a degraded and inactive species, but instead, it has
phosphatase activity. Although the𝐾
𝑚
value for the fragment
was somewhat higher than the 𝐾
𝑚
value for the hCaMKP-
N(WT), the 𝑉max value for the fragment was more than ten
times higher than that for theWT.Therefore, we suggest that
the truncation of C-terminal region 560–757 of hCaMKP-
N is a post-translational regulatory mechanism to generate
a highly active species.
The mechanism of activation by truncation remains
unclear. The truncated C-terminal region might act as
an autoinhibitory domain, as is the case for calcineurin
[23]. Alternatively, processing of the region might cause a
conformational change in its catalytic center that leads to
catalytic activation. It has been reported that some protein
phosphatases in the PPP family are activated by proteolysis
[24, 25]. We have also reported that zCaMKP-N is activated
by proteolytic processing of the C-terminal domain [9].
Therefore, activation by C-terminal truncation appears to
be a common feature for CaMKP-N, despite the fact that
hCaMKP-N and zCaMKP-N have fairly different molecular
sizes and primary structures. Because it has been reported
that rat CaMKP-N(1–554), a fragment corresponding to
hCaMKP-N(1–559), is localized in the cytosol of transfected
COS cells [10], the truncation of the C-terminal domain is
likely to regulate catalytic activity as well as the intracellular
localization of hCaMKP-N. Since inhibition of the proteolytic
processing of zCaMKP-N in Neuro2a cells by proteasome
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Figure 7:The binding of hCaMKP-N(1–559) to PSD and the dephosphorylation of the autophosphorylated CaMKII. (a) hCaMKP-N(1–559)
(1 𝜇g) was incubated on ice for 1 h with (lane 2) or without (lane 3) the PSD fraction (1 𝜇g) as described in Section 2. After incubation, the
mixture was centrifuged, and the pellet fraction was washed twice with 50mMTris-HCl (pH 7.5) containing 0.85%NaCl, followed by western
blotting analysis using anti-CaMKP-N antibody (upper panel). Recovery of the PSD fraction was confirmed by probing the same blot using
anti-CaMKII𝛼 antibody (lower panel). To check the endogenous CaMKP-N levels, the PSD fraction was also incubated in the absence of
hCaMKP-N(1–559) as a control (lane 1). (b)The PSD fraction (29 𝜇g/mL), in which CaMKII had been autophosphorylated as described, was
incubated at 30∘Cwith (lane 2) or without (lane 1) hCaMKP-N(1–559). After incubation for 30min, the phosphatase reaction was terminated
by adding excess EDTA (20mM), and aliquots were analyzed by western blotting to examine the extent of phosphorylation at Thr286 on
CaMKII (upper panel, anti-PCaMKII) and the total amount of CaMKII𝛼 on the blot (lower panel, anti-CaMKII𝛼). The data presented are
representative of at least three independent experiments with similar results.
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Figure 8:The reversible inactivation of hCaMKP-N(1–559) by H
2
O
2
. (a) hCaMKP-N(1–559) (245𝜇g/mL) was incubated on ice for 30min in
25mM Tris-HCl (pH 7.5) with or without the indicated concentrations of H
2
O
2
, and then the phosphatase activities were determined using
pp10 as the substrate. (b) hCaMKP-N(1–559) (245 𝜇g/mL) was incubated on ice for 30min in 25mM Tris-HCl (pH 7.5) with 5 mM H
2
O
2
,
and then DTT (50mM) was added for incubation on ice for an additional 30min.Thereafter, the phosphatase activity was determined using
pp10 as the substrate. As a comparison, the phosphatase activity without DTT treatment is also presented (5mMH
2
O
2
). The DTT treatment
itself had no significant effects on the activity of hCaMKP-N(1–559) in the control (50mM DTT). The results are expressed as a percentage
of the control activity (none), which was determined after incubation without any compounds (H
2
O
2
or DTT) added.The data represent the
average of three independent experiments ± S.D.
inhibitors significantly changed substrate targeting in the
cells [9], activation and translocation of the mammalian
CaMKP-N may also affect the intracellular substrate target-
ing.
The activated CaMKP-N fragment generated by the
proteolytic processing is reported to be the major species of
CaMKP-N in the rat brain [10]. Here, we show a molecular
characterization of the 90 kDa active fragment in human,
hCaMKP-N(1–559). It exhibited okadaic acid/calyculin A-
insensitive and Mn2+ or Mg2+-dependent phosphatase activ-
ity and demonstrated a striking preference for a phospho-
threonyl peptide over a phosphoseryl or a phosphotyrosyl
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peptide. These enzymatic properties are similar to those of
CaMKP [11]. However, the metal dependence of hCaMKP(1–
559) was somewhat different from that of CaMKP. Although
the half-maximal activation for Mn2+ is comparable to
that of rat CaMKP (∼0.2mM), activation by Mg2+ is more
prominent in hCaMKP(1–559) than it is in CaMKP [26].
Furthermore, hCaMKP-N(1–559) showed Mn2+-dependent
activity and comparable Mg2+-dependent activity at its sat-
urating levels. NaF is known to inhibit various protein phos-
phatases. Fluoride is reported to directly bind to the metal
ions in the active center of bovine purple acid phosphatase
[27]. Since Ser/Thr protein phosphatases are known to be
metalloenzymes that employ dinuclear metal center similar
to purple acid phosphatases [28], it is most likely that fluoride
also binds to the metal center to inhibit its phosphatase
activity. Interestingly, ANDS, a potent inhibitor for CaMKP
[18], did not inhibit the phosphatase activity of hCaMKP-
N(1–559). This suggests that the three-dimensional structure
of the active site of hCaMKP-N is considerably different from
that of rat CaMKP even though their primary structures of
their putative catalytic regions are highly homologous.
hCaMKP-N(1–559) could bind to PSD to dephospho-
rylate the CaMKII associated with it. Based on electron
microscope results, the correspondingCaMKP-N fragment is
suggested to be concentrated in PSD together with CaMKII
in rat brain [10]; however, the endogenous rat CaMKP-N
fragment was not detected in the isolated PSD fraction.
Therefore, it is likely that the CaMKP-N fragment is not a
component of PSD, but its binding to PSD is dynamically
regulated in neuronal cells. This fragment might be involved
in regulation of CaMKII activity in PSD, where synaptic
transmission is tightly controlled. The CaMKP-N activated
by proteolysis might be a critical regulator for synaptic
transmission through controlling the phosphorylation state
of the CaMKII in PSD.
Another notable finding in this study is that hCaMKP-
N(1–559) is inactivated by H
2
O
2
treatment, and reactivated
by incubation with DTT. Recently, we reported that human
CaMKP is reversibly regulated by oxidation/reduction at
Cys359 [19]. This Cys residue is adjacent to an Asp residue
that is essential for metal binding at the active site, and the
Cys-Asp sequence is conserved in the catalytic sites of many
PPM family enzymes including hCaMKP-N. Therefore, the
observed inactivation of hCaMKP-N(1–559) might be due to
reversible oxidation at Cys436 of hCaMKP-N. The reversible
regulation of the phosphatase activity of hCaMKP-N(1–559)
by oxidation/reduction may be an important mechanism for
regulating the phosphorylation levels of CaMKII in neuronal
cells, especially in PSD, in response to oxidative stress.
In summary, we showed for the first time that hCaMKP-
N is activated through truncation of the C-terminal domain.
The active truncated fragment could bind to PSD to dephos-
phorylate CaMKII, and its enzymatic properties were similar
to those of CaMKP except for its Mg2+-dependence and
sensitivity to ANDS. Very recently, genome-wide associa-
tion studies suggested that single nucleotide polymorphisms
found in the loci for CaMKP-N (PPM1E) and for CaMKP
(PPM1F) are associated with testicular germ cell tumor [29]
and with both schizophrenia and bipolar disorders [30],
respectively. Since hCaMKP-N(1–559) is supposedly localized
in the cytosol where CaMKP is found, the next important
question concerns what are the roles that CaMKP and the
active CaMKP-N fragment share in the cytosol. Further work
is needed to address this question.
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